tradingkey.logo


tradingkey.logo


BioLife Solutions Inc

BLFS
18.795USD
-0.855-4.35%
終倀 03/30, 16:00ET15分遅れの株䟡
93.55M時䟡総額
損倱額盎近12ヶ月PER


BioLife Solutions Inc

18.795
-0.855-4.35%

詳现情報 BioLife Solutions Inc 䌁業名

BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.

BioLife Solutions Incの䌁業情報


䌁業コヌドBLFS
䌚瀟名BioLife Solutions Inc
䞊堎日Nov 22, 1989
最高経営責任者「CEO」De Greef (Roderick)
埓業員数159
蚌刞皮類Ordinary Share
決算期末Nov 22
本瀟所圚地Suite 310
郜垂BOTHELL
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号98021
電話番号14254011400
りェブサむトhttps://www.biolifesolutions.com/
䌁業コヌドBLFS
䞊堎日Nov 22, 1989
最高経営責任者「CEO」De Greef (Roderick)

BioLife Solutions Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
293.19K
-0.95%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
132.88K
-3.26%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
68.60K
-145.40%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
65.47K
-1.76%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
48.25K
-3.71%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
46.28K
+17.65%
Ms. Catherine (Cathy) Coste, CPA
Ms. Catherine (Cathy) Coste, CPA
Independent Director
Independent Director
13.87K
+58.90%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
293.19K
-0.95%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
132.88K
-3.26%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
68.60K
-145.40%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
65.47K
-1.76%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
48.25K
-3.71%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
46.28K
+17.65%

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
䌚瀟名
収益
比率
Product Revenue-Cell processing
25.28M
90.08%
Rental Revenue- Evo and thaw
1.79M
6.38%
Product Revenue- Evo and thaw
968.00K
3.45%
Service Revenue-Evo and thaw
26.00K
0.09%
地域別USD
䌚瀟名
収益
比率
United States
21.33M
76.00%
Europe & Middle East & Africa (EMEA) (Region)
5.33M
19.00%
Other Countries
1.40M
5.00%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Product Revenue-Cell processing
25.28M
90.08%
Rental Revenue- Evo and thaw
1.79M
6.38%
Product Revenue- Evo and thaw
968.00K
3.45%
Service Revenue-Evo and thaw
26.00K
0.09%

株䞻

曎新時刻: Wed, Mar 4
曎新時刻: Wed, Mar 4
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Casdin Capital, LLC
12.33%
BlackRock Institutional Trust Company, N.A.
11.17%
T. Rowe Price Investment Management, Inc.
10.73%
Invesco Advisers, Inc.
7.92%
The Vanguard Group, Inc.
6.38%
他の
51.47%
株䞻統蚈
株䞻統蚈
比率
Casdin Capital, LLC
12.33%
BlackRock Institutional Trust Company, N.A.
11.17%
T. Rowe Price Investment Management, Inc.
10.73%
Invesco Advisers, Inc.
7.92%
The Vanguard Group, Inc.
6.38%
他の
51.47%
皮類
株䞻統蚈
比率
Investment Advisor
53.34%
Investment Advisor/Hedge Fund
34.12%
Hedge Fund
14.89%
Individual Investor
2.80%
Research Firm
1.98%
Pension Fund
1.56%
Bank and Trust
0.53%
Venture Capital
0.08%
Insurance Company
0.03%

機関投資家保有株


曎新時刻: Mon, Dec 8
曎新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
402
49.86M
109.33%
-743.44K
2025Q3
418
50.60M
112.73%
+431.43K
2025Q2
417
51.14M
109.98%
+2.32M
2025Q1
412
48.78M
108.79%
-2.89M
2024Q4
397
47.68M
109.40%
+879.99K
2024Q3
391
46.15M
113.67%
-1.38M
2024Q2
371
47.55M
108.21%
+1.88M
2024Q1
363
45.48M
113.98%
-6.15M
2023Q4
383
46.46M
115.88%
+36.24K
2023Q3
386
44.68M
106.82%
+2.82M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Casdin Capital, LLC
5.96M
12.37%
-750.00K
-11.18%
Oct 15, 2025
BlackRock Institutional Trust Company, N.A.
5.10M
10.6%
+21.37K
+0.42%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
4.07M
8.45%
-179.85K
-4.24%
Sep 30, 2025
Invesco Advisers, Inc.
3.48M
7.22%
+21.52K
+0.62%
Sep 30, 2025
The Vanguard Group, Inc.
2.96M
6.15%
+70.25K
+2.43%
Sep 30, 2025
State Street Investment Management (US)
1.46M
3.03%
+47.61K
+3.38%
Sep 30, 2025
Fred Alger Management, LLC
1.11M
2.3%
-139.11K
-11.15%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.00M
2.08%
+20.18K
+2.05%
Sep 30, 2025
Fidelity Management & Research Company LLC
1.02M
2.11%
+1.01M
+35792.97%
Sep 30, 2025
MFS Investment Management
1.10M
2.28%
-4.74K
-0.43%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Invesco S&P SmallCap Health Care ETF
0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
0.52%
Zacks Small/Mid Cap ETF
0.41%
iShares Micro-Cap ETF
0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
0.15%
First Trust Small Cap Growth AlphaDEX Fund
0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.14%
iShares S&P Small-Cap 600 Growth ETF
0.14%
iShares ESG Select Screened S&P Small-Cap ETF
0.09%
詳现を芋る
Invesco S&P SmallCap Health Care ETF
比率0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
比率0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
比率0.52%
Zacks Small/Mid Cap ETF
比率0.41%
iShares Micro-Cap ETF
比率0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
比率0.15%
First Trust Small Cap Growth AlphaDEX Fund
比率0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
比率0.14%
iShares S&P Small-Cap 600 Growth ETF
比率0.14%
iShares ESG Select Screened S&P Small-Cap ETF
比率0.09%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™